|
RSF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.35649999975097E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.524930E-03 |
| Normal-vs-Stage2 |
2.863300E-03 |
| Normal-vs-Stage3 |
2.57870003128602E-09 |
| Normal-vs-Stage4 |
2.34700003876043E-09 |
| Stage1-vs-Stage2 |
4.767600E-01 |
| Stage1-vs-Stage3 |
3.579400E-04 |
| Stage1-vs-Stage4 |
1.007190E-04 |
| Stage2-vs-Stage3 |
7.096000E-02 |
| Stage2-vs-Stage4 |
5.178400E-02 |
| Stage3-vs-Stage4 |
6.304200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.20790000005078E-06 |
| Normal-vs-AfricanAmerican |
4.7247000000139E-06 |
| Normal-vs-Asian |
2.950600E-01 |
| Caucasian-vs-AfricanAmerican |
1.617040E-01 |
| Caucasian-vs-Asian |
5.489800E-01 |
| AfricanAmerican-vs-Asian |
2.938400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99579999971E-07 |
| Normal-vs-Female |
2.599100E-04 |
| Male-vs-Female |
7.207700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.643500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.611100E-04 |
| Normal-vs-Age(61-80Yrs) |
4.23970000218432E-08 |
| Normal-vs-Age(81-100Yrs) |
7.84169999999973E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.275800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.439800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.670400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.577700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.870300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.370600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.957000E-01 |
| Normal-vs-Grade 2 |
4.543600E-03 |
| Normal-vs-Grade 3 |
7.59370011316207E-10 |
| Normal-vs-Grade 4 |
1.02340003138579E-09 |
| Grade 1-vs-Grade 2 |
3.275700E-02 |
| Grade 1-vs-Grade 3 |
6.32569999999832E-05 |
| Grade 1-vs-Grade 4 |
2.15359999999887E-05 |
| Grade 2-vs-Grade 3 |
1.627930E-04 |
| Grade 2-vs-Grade 4 |
8.18129999999861E-05 |
| Grade 3-vs-Grade 4 |
1.080400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.853700E-02 |
| Normal-vs-ccB subtype |
4.36320000130053E-08 |
| ccA subtype-vs-ccB subtype |
1.62127999999706E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.10219999999362E-06 |
| Normal-vs-N1 |
5.784500E-04 |
| N0-vs-N1 |
2.418600E-01 |
|
|
